Effect of home monitoring via mobile app on the number of in-person visits following ambulatory surgery. A randomized clinical trial. JAMA Surg 2017; 152: 622-627.
Published: 6th October 2017
Authors: Armstrong K, Coyte PC, Brown, M, Beber B, Semple JL
Sixty-five women recovering from breast reconstruction were randomized to follow-up by mobile app or in person visits for 30 days after surgery. Women who used the app had fewer in person hospital visits and reported improved convenience scores.Pubmed Link
You may also be interested in
Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer. The SCALP randomized clinical trial. JAMA 2017; 317: 596-605.
Authors: Nangia J, Wang T, Osborne C, Niravath P, Otte K, Papish S et al.
Telehealth system: a randomized controlled trial evaluating the impact of an internet-based exercise intervention on quality of life, pain, muscle strength, and fatigue in breast cancer survivors. Cancer 2016; 122: 3166-3174.
Authors: Galiano-Castillo N, Cantarero-Villaneuva I , Fernández-Lao C, Ariza-García A, Díaz-Rodríguez L, Del-Moral-Ávila R et al.
SIS.NET: A randomized controlled trial evaluating a web-based system for symptom management after treatment of breast cancer. Cancer 2015; 121: 893–899.
Authors: Wheelock E, Bock MA, Martin EL, Hwang J, Ernest ML, Rugo HS et al. et al.
Comparison of doxorubicin and cyclophosphamide versus single agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance). J Clin Oncol 2014; 32: 2311-2317.
Authors: Schulman LN, Berry DA, Cirrincione CT, Becker HP, Perez EA, O'Regan R et al. et al.
Randomized controlled trial of yoga in women with breast cancer undergoing radiotherapy. J Clin Oncol 2014; 32: 1058-1065.
Authors: Chandwani KD, Perkins G, Nagendra HR, Raghuram NV, Spelman A, Nagarathna R et al. et al.
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-III): an international, double-blind, randomised placebo-controlled trial. Lancet 2014; 383: 1041-1048.
Authors: Cuzik J, Sestak I, Forbes JF, Dowsett M, Know J, Cawthorn S et al. et al.
Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms. Cancer 2014; 120: 381-389.
Authors: Bao T, Cai L, Snyder C, Betts K, Tarpinian K, Gould JA et al. et al.
Effects of exercise dose and type during breast cancer chemotherapy: multicenter randomized trial. J Natl Cancer Inst 2013; 105: 1821-1832.
Authors: Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Friedenreich CM, Yasui Y et al. et al.
Reducing treatment decision conflict difficulties in breast cancer surgery: a randomised controlled trial. J Clin Oncol 2013; 31: 2879–2885.
Authors: Lam WW, Chan M, Or A, Kwong A, Suen D, Fielding R et al.
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomised trials. J Clin Oncol 2011; 29: 3224–3231.
Authors: Berry DA, Ueno NT, Johnson MM, Lei X, Caputo J, Smith DA et al. et al.
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010; 375: 563-571.
Authors: Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V et al. et al.
Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial BMJ 2009; 338: 337-340
Authors: Beaver K, Tysver-Robinson D, Campbell M, Twomey M, Williamson S, Hindley A et al et al.